Status:
RECRUITING
Greater Manchester CARDIOvascular Pathology in Immune-Mediated Inflammatory Diseases
Lead Sponsor:
University of Manchester
Conditions:
Cardiovascular Diseases
Rheumatologic Disease
Eligibility:
All Genders
18+ years
Brief Summary
The researchers would like to know more about cardiovascular abnormalities in patients with immune-mediated inflammatory diseases (IMID) and with the aim to provide new biomarkers (clinical, blood, im...
Detailed Description
Immune-mediated-inflammatory-diseases (IMID) are a range of illnesses affecting over 1 million people in the UK. Targeted treatments have changed outcomes of common IMIDs, but mortality is still high...
Eligibility Criteria
Inclusion
- Main Study
- Males and females
- Subjects aged over 18 years
- Capable of providing informed consent and signing a consent form
- Have a clear diagnosis of an IMID with history consistent with one of the following categories:
- IMID-'at risk' CVD: individuals who have a risk of developing CVD (based on traditional risk factors and/or IMID-specific factors) but no history of major adverse cardiovascular events (MACE).
- Incident (new) IMID-CVD: Patients with IMID that present with a MACE.
- Established IMID-CVD: Patients with IMID and a history of previous MACE
Exclusion
- Age less than 18 years
- Lack of capacity to give informed consent
- Imaging Sub-Study
- Inclusion Criteria:
- \- As-listed for Main Study
Key Trial Info
Start Date :
September 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2032
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT06600737
Start Date
September 30 2024
End Date
September 1 2032
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, Greater Manchester, United Kingdom, M13 9WL